کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
11017136 | 1748460 | 2018 | 15 صفحه PDF | دانلود رایگان |
عنوان انگلیسی مقاله ISI
COPD Guidelines: A Review of the 2018 GOLD Report
دانلود مقاله + سفارش ترجمه
دانلود مقاله ISI انگلیسی
رایگان برای ایرانیان
کلمات کلیدی
CATFVCICSMMRCFEV1Sao2NIPPVAECOPDLAMA - OLDCOPD Assessment Test - آزمون ارزیابی COPDlong-acting muscarinic antagonist - آنتاگونیست muscarinic طولانی مدتCOPD - بیماری مزمن انسدادی ریهChronic obstructive pulmonary disease - بیماری مزمن انسدادی ریهacute exacerbation of COPD - تشدید حاد COPDNoninvasive positive pressure ventilation - تهویه فشار غیر انسدادی مثبتLABA - سودModified Medical Research Council - شورای تحقیقات پزشکی اصلاح شدهGlobal Initiative for Chronic Obstructive Lung Disease - طرح جهانی برای بیماری مزمن ریوی مزمنGold - طلاforced vital capacity - ظرفیت حیاتی اجباریforced expiratory volume in 1 second - مجاز خروج مجدد در 1 ثانیهInhaled corticosteroid - کورتیکواستروئیدهای استنشاقی
موضوعات مرتبط
علوم پزشکی و سلامت
پزشکی و دندانپزشکی
کاردیولوژی و پزشکی قلب و عروق
پیش نمایش صفحه اول مقاله
![عکس صفحه اول مقاله: COPD Guidelines: A Review of the 2018 GOLD Report COPD Guidelines: A Review of the 2018 GOLD Report](/preview/png/11017136.png)
چکیده انگلیسی
Global Strategy for the Diagnosis, Management, and Prevention of COPD 2018 is a consensus report published periodically since 2001 by an international panel of health professionals from respiratory medicine, socioeconomics, public health, and education comprising the Global Initiative for Chronic Obstructive Lung Disease (GOLD). The GOLD documents endeavor to incorporate latest evidence and expert consensus and are intended for use as “strategy documents” for implementation of effective care for chronic obstructive lung disease (COPD) on a global level. The GOLD 2018 report defines COPD as a “common, preventable and treatable disease that is characterized by persistent respiratory symptoms and airflow limitation that is due to airway and/or alveolar abnormalities, usually caused by significant exposure to noxious particles or gases,” with the criteria of “persistent respiratory symptoms” being a new and controversial inclusion since 2017. With the availability of newer pharmacotherapy options, treatment recommendations are made on the basis of a review of the latest literature and directed by symptom burden and health care utilization. Apart from the change in definition, a major shift in the recommendations is the exclusion of severity of airflow limitation as one of the major factors in guiding therapy. We review the salient features of the GOLD 2018 document and provide commentary on features that merit further discussion based on our clinical experience and practice as well as literature review current as of February 2018.
ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Mayo Clinic Proceedings - Volume 93, Issue 10, October 2018, Pages 1488-1502
Journal: Mayo Clinic Proceedings - Volume 93, Issue 10, October 2018, Pages 1488-1502
نویسندگان
Shireen MBBS, Ryan D. MD, Matthew A. MD, Paul D. MD,